Gang Zeng
Department of Urology
David Geffen School of Medicine at UCLA
10833 Le Conte Ave
Los Angeles
USA
Name/email consistency: high
- A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. Xie, C., Kim, H.J., Haw, J.G., Kalbasi, A., Gardner, B.K., Li, G., Rao, J., Chia, D., Liong, M., Punzalan, R.R., Marks, L.S., Pantuck, A.J., de la Taille, A., Wang, G., Mukouyama, H., Zeng, G. J. Transl. Med (2011)
- Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. Zeng, G., Aldridge, M.E., Tian, X., Seiler, D., Zhang, X., Jin, Y., Rao, J., Li, W., Chen, D., Langford, M.P., Duggan, C., Belldegrun, A.S., Dubinett, S.M. J. Immunol. (2006)
- Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Zeng, G., Aldridge, M.E., Wang, Y., Pantuck, A.J., Wang, A.Y., Liu, Y.X., Han, Y., Yuan, Y.H., Robbins, P.F., Dubinett, S.M., deKernion, J.B., Belldegrun, A.S. Int. J. Cancer (2005)
